Literature DB >> 6620156

Determination of hydrazine in pharmaceuticals III: hydralazine and isoniazid using GLC.

F Matsui, D L Robertson, E G Lovering.   

Abstract

A GLC procedure has been developed for the determination of hydrazine in hydralazine and isoniazid drug raw materials, single and multicomponent tablets, injectables, and syrups. The method is based on the derivatization of hydrazine with benzaldehyde to form benzalazine. The minimum detectable amount of hydrazine in hydralazine and isoniazid raw materials and formulations is approximately 0.0003%. No hydrazine was found in the hydralazine raw material specimens examined. Traces of hydrazine (approximately 0.0003%) were found in some tablet lots and approximately 0.02% was found in an injectable product. A trace of hydrazine was found in one lot of isoniazid raw material and low levels (0.0012 and 0.0029%) were found in isoniazid tablet products. An isoniazid syrup contained approximately 0.2% hydrazine.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6620156     DOI: 10.1002/jps.2600720829

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  1 in total

1.  Quantification of Hydrazine in Human Urine by HPLC-MS-MS.

Authors:  Samantha L Isenberg; Melissa D Carter; Brian S Crow; Leigh Ann Graham; Darryl Johnson; Nick Beninato; Kandace Steele; Jerry D Thomas; Rudolph C Johnson
Journal:  J Anal Toxicol       Date:  2016-03-13       Impact factor: 3.367

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.